- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:08 | FDA waves through a third Sarepta DMD drug, once again based on questionable biomarker data | ||
| 17:08 | Rocket Pharma spurs more buildings and landmarks to light up for Rare Disease Day | ||
| 16:08 | Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail | ||
| 16:08 | Fierce Pharma Asia-Daiichi Sankyo's new R&D head; Clover's $230M raise; Insilico's AI breakthrough | ||
| Do | Bayer looks for pharma growth in 2021 as new drugs start to take shape | ||
| Do | Three-shot combo? Pfizer, BioNTech roll COVID-19 booster trial as real world data back first vaccine | ||
| Do | Ready to square off with Pfizer in next-gen pneumococcal vaccines, a Merck exec says competition's a good thing | ||
| Do | Novo Nordisk plots $82M tablet capacity upgrade for diabetes blockbuster-to-be Rybelsus | ||
| Do | Moderna has sewn up $18 billion in COVID-19 vaccine orders-and it's negotiating more | ||
| Do | Mission Possible: Pfizer and BioNTech star in their own vaccine discovery movie | ||
| Mi | Moderna sends COVID-19 booster shot for NIH testing as it hikes production targets past 2B doses | ||
| Mi | Want to bet on Big Pharma? M&A hunger, pricing pressure increase the risk, ratings agency says | ||
| Mi | Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site | ||
| Mi | AstraZeneca to tap global COVID vaccine supply chain to fulfill second-quarter deliveries to Europe | ||
| Mi | Novartis' first Kesimpta ad push proffers break from relapsing MS 'drama' | ||
| Mi | Catalent continues cell and gene therapy push with deal for Belgian CDMO | ||
| Di | Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts | ||
| Di | Pfizer eyes higher prices for COVID-19 vaccine after the pandemic wanes: exec, analyst | ||
| Di | Bristol Myers signs Pitch Perfect star Ben Platt for multiple sclerosis music therapy campaign | ||
| Di | Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst | ||
| Di | Johnson & Johnson tots up a potential $4B talc bill as tens of thousands of lawsuits pile up | ||
| Di | Pfizer, Moderna and J&J tout supercharged COVID-19 vaccine output, eyeing nearly 140 million doses by March | ||
| Di | Sanofi, Regeneron's Libtayo snags lung cancer nod, taking a stab at Keytruda's megablockbuster lead | ||
| Di | Nasal spray prevents COVID-19 transmission in preclinical tests | ||
| Di | Almirall bags EU rights to topical psoriasis drug from MC2 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
